BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28028400)

  • 21. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
    Ben-Assa E; Rengifo-Moreno P; Al-Bawardy R; Kolte D; Cigarroa R; Cruz-Gonzalez I; Sakhuja R; Elmariah S; Pomerantsev E; Vaina LM; Ning M; Buonanno FS; Hung JW; Inglessis I; Palacios IF
    JACC Cardiovasc Interv; 2020 Feb; 13(3):293-302. PubMed ID: 32029246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Percutaneous closure of patent foramen ovale: a wise approach].
    Gaspardone A; Iani C; Papa M
    G Ital Cardiol (Rome); 2008 Sep; 9(9):593-602. PubMed ID: 18783080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS
    Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment.
    Wahl A; Praz F; Findling O; Nedeltchev K; Schwerzmann M; Tai T; Windecker S; Mattle HP; Meier B
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):124-9. PubMed ID: 19180663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early post-procedural migraine attack predicts migraine resolution after patent foramen ovale transcatheter closure.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Braggion G; Giordan M; Chinaglia M
    Minerva Cardioangiol; 2008 Oct; 56(5):461-5. PubMed ID: 18813181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coincidental Impact of Transcatheter Patent Foramen Ovale Closure on Migraine with and without Aura - A Comprehensive Meta-Analysis.
    Kanwar SM; Noheria A; DeSimone CV; Rabinstein AA; Asirvatham SJ
    Clin Trials Regul Sci Cardiol; 2016 Mar; 15():7-13. PubMed ID: 26949743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new era in patent foramen ovale closure - a percutaneous suture-based 'deviceless' technique (NobleStitch®): Experience of a Portuguese center.
    Neto A; Resende CX; Tavares Silva M; Silva JC; Macedo F
    Rev Port Cardiol; 2023 Jan; 42(1):53-59. PubMed ID: 36116990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidisciplinary assessment of PFO with substantial right-to-left shunting and medium-term follow-up after PFO device closure: A single-center experience.
    He L; Cheng GS; Du YJ; Zhang YS
    J Interv Cardiol; 2017 Aug; 30(4):362-367. PubMed ID: 28568903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seven-year follow-up of percutaneous closure of patent foramen ovale.
    Mirzada N; Ladenvall P; Hansson PO; Johansson MC; Furenäs E; Eriksson P; Dellborg M
    Int J Cardiol Heart Vessel; 2013 Dec; 1():32-36. PubMed ID: 29450155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes after percutaneous patent foramen ovale closure.
    Nagpal SV; Lerakis S; Flueckiger PB; Halista M; Willis P; Block PC; Douglas JS; Morris DC; Liff DA; Stewart J; Devireddy C; Veledar E; Nahab FB; Babaliaros VC
    Am J Med Sci; 2013 Sep; 346(3):181-6. PubMed ID: 23328836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
    Rengifo-Moreno P; Palacios IF; Junpaparp P; Witzke CF; Morris DL; Romero-Corral A
    Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: A single-center prospective study.
    Zhao E; Liu W; Zhang Y; Cheng G; Du Y; He L; Wang X; He X
    Medicine (Baltimore); 2017 Apr; 96(14):e6572. PubMed ID: 28383438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke.
    Giardini A; Donti A; Formigari R; Salomone L; Palareti G; Guidetti D; Picchio FM
    Catheter Cardiovasc Interv; 2006 Apr; 67(4):625-9. PubMed ID: 16548006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yu CM
    Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter closure of patent foramen ovale: a new migraine treatment?
    Morandi E; Anzola GP; Angeli S; Melzi G; Onorato E
    J Interv Cardiol; 2003 Feb; 16(1):39-42. PubMed ID: 12664816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
    Davies A; Ekmejian A; Collins N; Bhagwandeen R
    Heart Lung Circ; 2017 Mar; 26(3):246-250. PubMed ID: 27555053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
    Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
    Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
    Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
    J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propensity-score matched analysis of patent foramen ovale closure in real-world study cohort with cryptogenic ischemic stroke.
    Low CE; Teo YN; Teo YH; Lim ICZ; Rana S; Lee YQ; Chen X; Fang JT; Lam HH; Ong K; Yang J; Kuntjoro I; Low TT; Lee EC; Sharma VK; Yeo LL; Sia CH; Tan BY; Lim Y
    J Stroke Cerebrovasc Dis; 2023 Dec; 32(12):107407. PubMed ID: 37804781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.